Atezolizumab,Cabozantinib,tivozanib,nivolumab
Roche,Aveo Oncology,BMS
[' uc,(-ucsd),(-ucsf),', 'nivo', 'congrat']
congrats et al. on publishing this very important phase 3 trial the question was very important, also awaiting t-nivo2 data! opportunity to ask similar question in uc 
Oncologist, Professor, clinical/translational research, Genitourinary Cancers, bladder, prostate, testis, Univ of Washington, Fred Hutch; views are mine